封面
市場調查報告書
商品編碼
1490017

微生物組定序服務市場:按服務類型、按應用、按最終用戶、按地區

Microbiome Sequencing Service Market, By Service Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

微生物組定序服務的全球市場規模估計到2024年為 19.7 億美元,預計到2031年將達到 41.3 億美元,2024年至2031年的年複合成長率為 11.1%。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 19.7億美元
實際資料 2019年至2023年 預測期 從2024年到2031年
預測2024-2031年年複合成長率: 11.10% 2031年價值預測 41.3億美元
圖:2024年依地區分類的微生物組定序服務市場佔有率(%)
微生物組定序服務市場-IMG1

微生物組定序使用高通量定序技術來研究人體內部和與人體相關的微生物群落。人類微生物組是指體內存在的所有微生物的基因組。次世代定序技術的進步使得微生物群落的分析達到了前所未有的規模和解析度。微生物組定序服務透過標靶基因定序或全元基因組鳥槍定序提供各種微生物群落的基因組分析。這徹底改變了對微生物組與各種人類疾病、病理和藥物反應之間關係的理解。研究身體內部和表面存在的複雜微生物生態系統可以為人類健康提供有價值的見解,並開啟新的診斷、預後和治療方法的可能性。

市場動態:

微生物組定序服務的全球市場受到各種疾病研究和藥物開發活動中擴大採用微生物組分析的推動。微生物組研究顯示腸道微生物與多種疾病之間存在聯繫,包括肥胖、糖尿病、癌症以及神經和免疫疾病。這推動製藥和生物技術公司對基於微生物組的治療開發的投資。然而,由於大規模全宏基因組鳥槍法定序服務的成本較高,市場潛力仍受到限制。持續研究和開發負擔得起的定序技術代表了市場擴張的重大機會。擴大微生物組分析在個人化營養和益生菌產品開發的應用也提供了良好的前景。微生物組分析公司和最終用戶之間的合​​作越來越有助於開拓新的應用領域。

本研究的主要特點

  • 這份研究報告對全球微生物組定序服務市場進行了詳細分析,並提供了以2023年為基準年的預測期(2024-2031年)的市場規模和年複合成長率(CAGR%)。
  • 強調了各個細分市場的潛在收益成長機會,並說明了該市場有吸引力的投資提案矩陣。
  • 提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 根據公司亮點、產品系列、主要亮點,實績和策略等參數,介紹了全球微生物組定序服務市場的主要企業。
  • 主要企業包括 Microbiome Insights Inc.、Baseclear BV、Clinical Microbiomics A/S.、Merieux NutriSciences Corporation、MR DNA、Zymo Research Corporation、Metabiomics Corp.、uBiome, Inc.、Microbiome Therapeutics Innovation Group、Locus Biosciences, Inc.、OpenBiome、Shanghai Ruiyi Biotechnology Co.KG、BioSpherex LLC、Diversigen。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 微生物組定序服務的全球市場迎合了該行業的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球微生物組定序服務市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管場景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章 全球微生物組定序服務市場-冠狀病毒(COVID-19)大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第5章 全球微生物組定序服務市場,依服務類型,2019-2031

  • 6S rRNA 基因分析
  • 全基因組鳥槍法定定序
  • 標靶基因序列測定序
  • 單細胞定序
  • 其他

第6章 全球微生物組定序服務市場,依應用,2019-2031

  • 腸道微生物群分析
  • 尿液微生物群分析
  • 其他

第7章 全球微生物定序服務市場,依最終使用者分類,2019-2031年

  • 學術研究所
  • 製藥和生物技術公司
  • 診斷實驗室
  • 其他

第8章 全球微生物組定序服務市場,依地區,2019-2031

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • 公司簡介
    • Microbiome Insights Inc.
    • Baseclear BV
    • Clinical Microbiomics A/S
    • Merieux NutriSciences Corporation
    • MR DNA
    • Zymo Research Corporation
    • Metabiomics Corp.
    • uBiome, Inc.
    • Microbiome Therapeutics Innovation Group
    • Locus Biosciences, Inc.
    • OpenBiome
    • Shanghai Ruiyi Biotechnology Co., Ltd.
    • Resphera Biosciences, LLC
    • Molzym GmbH &Co. KG
    • BioSpherex LLC
    • Diversigen

第10章 分析師建議

  • Wheel of Fortune
  • 分析師觀點
  • Coherent Opportunity Map

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI6980

Global microbiome sequencing service market is estimated to be valued at USD 1.97 Bn in 2024 and is expected to reach USD 4.13 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 1.97 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 11.10% 2031 Value Projection: US$ 4.13 Bn
Figure. Microbiome Sequencing Service Market Share (%), By Region 2024
Microbiome Sequencing Service Market - IMG1

Microbiome sequencing involves using high-throughput sequencing technologies to study the microbial communities within and associated with the human body. The human microbiome refers to the genomes of all microorganisms that reside on or within bodies. Advances in next-generation sequencing technologies have enabled the analysis of microbial communities at an unprecedented scale and resolution. Microbiome sequencing services provide genomic analysis of various microbial communities through targeted gene sequencing or whole metagenomic shotgun sequencing. This has transformed our understanding of the connections between the microbiome and various diseases, conditions, and drug responses in humans. By studying the complex microbial ecosystems in and on our bodies, we can gain valuable insights into human health and open up possibilities for novel diagnostics, prognostics, and therapeutics.

Market Dynamics:

The global microbiome sequencing service market is driven by the rising adoption of microbiome analysis in various disease research and drug development activities. Microbiome research has shown links between gut microbes and various diseases like obesity, diabetes, cancer, and neurological and immune disorders. This is encouraging more investments by pharmaceutical and biotech firms into microbiome-based therapy development. However, the market potential is still restrained by the high costs associated with large-scale whole metagenomic shotgun sequencing services. Ongoing R&D into affordable sequencing techniques presents a major opportunity for market expansion. Growing application of microbiome profiling for developing personalized nutrition and probiotic-based products also present lucrative prospects. Partnerships between microbiome analysis firms and end-users are increasingly helping to tap new application segments.

Key Features of the Study:

  • This report provides an in-depth analysis of the global microbiome sequencing service market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global microbiome sequencing service market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Microbiome Insights Inc., Baseclear B.V., Clinical Microbiomics A/S, Merieux NutriSciences Corporation, MR DNA, Zymo Research Corporation, Metabiomics Corp., uBiome, Inc., Microbiome Therapeutics Innovation Group, Locus Biosciences, Inc., OpenBiome, Shanghai Ruiyi Biotechnology Co., Ltd., Resphera Biosciences, LLC, Molzym GmbH & Co. KG, BioSpherex LLC, and Diversigen.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global microbiome sequencing service market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microbiome sequencing service market.

Detailed Segmentation-

  • By Service Type:
    • 6S rRNA gene profiling
    • Whole genome shotgun sequencing
    • Targeted gene sequencing
    • Single-cell sequencing
    • Others
  • By Application:
    • Gut microbiome analysis
    • Urinary microbiome analysis
    • Others
  • By End User:
    • Academic and research institutes
    • Pharmaceutical and Biotechnology companies
    • Diagnostic laboratories
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Microbiome Insights Inc.
    • Baseclear B.V.
    • Clinical-Microbiomics A/S
    • Merieux NutriSciences Corporation
    • MR DNA
    • Zymo Research Corporation
    • Metabiomics Corp.
    • uBiome, Inc.
    • Microbiome Therapeutics Innovation Group
    • Locus Biosciences, Inc.
    • OpenBiome
    • Shanghai Ruiyi Biotechnology Co., Ltd.
    • Resphera Biosciences, LLC
    • Molzym GmbH & Co. KG
    • BioSpherex LLC
    • Diversigen

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Microbiome Sequencing Service Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Microbiome Sequencing Service Market, By Service Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • 6S rRNA gene profiling
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Whole genome shotgun sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Targeted gene sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Single-cell sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Microbiome Sequencing Service Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Gut microbiome analysis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Urinary microbiome analysis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Microbiome Sequencing Service Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Academic and research institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pharmaceutical and Biotechnology companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Diagnostic laboratories
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Microbiome Sequencing Service Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Microbiome Insights Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Baseclear B.V.
    • Clinical Microbiomics A/S
    • Merieux NutriSciences Corporation
    • MR DNA
    • Zymo Research Corporation
    • Metabiomics Corp.
    • uBiome, Inc.
    • Microbiome Therapeutics Innovation Group
    • Locus Biosciences, Inc.
    • OpenBiome
    • Shanghai Ruiyi Biotechnology Co., Ltd.
    • Resphera Biosciences, LLC
    • Molzym GmbH & Co. KG
    • BioSpherex LLC
    • Diversigen

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact